ERBB2 and breast carcinoma: Our results indicate that the loss of colony-forming ability in both of the HER2-positive breast cancer cells upon treatment with the chalcone compounds DK-13 or -14, compared to the corresponding controls, indicates the tumor suppressor ability of these compounds in in vivo.